Inventor
DEN HARTOG JACOBUS A J
NL18 patents
⚠️ This page may combine multiple inventors who share the name “DEN HARTOG JACOBUS A J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DUPHAR INT RES
8 patentsUS6350750B1Feb 26, 2002
Quinoline and quinazoline derivatives having corticotropin releasing factor (CRF) antagonist activity
DUPHAR INT RES26 citations89
US6335326B1Jan 1, 2002
Benzisoxazole derivatives having d4-antagonistic activity
DUPHAR INT RES9 citations72
US6090812AJul 18, 2000
Piperazine and piperidine compounds
DUPHAR INT RES13 citations71
US6281216B1Aug 28, 2001
2-aminoquinoline derivatives having d4-agonistic activity
DUPHAR INT RES2 citations60
US5281595AJan 25, 1994
Alkylenedioxyphenyl ether derivatives having anti-ischaemic, memory enhancing and anti-convulsive activity
DUPHAR INT RES2 citations56
US5140024AAug 18, 1992
1,4-diazepine derivatives having anti-ulcer activity
DUPHAR INT RES0 citations51
US4985423AJan 15, 1991
New 1,4-diazepine derivatives having anit-ulcer activity
DUPHAR INT RES1 citations51
USRE41425EJul 6, 2010
Piperazine and piperidine compounds
DUPHAR INT RES0 citations50
SOLVAY PHARM BV
4 patentsUS7307079B2Dec 11, 2007
1,3,5-Triazine derivatives as ligands for human adenosine-A3 receptors
SOLVAY PHARM BV9 citations68
US7851630B2Dec 14, 2010
Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
SOLVAY PHARM BV4 citations60
US7371737B2May 13, 2008
2-substituted-6-trifluoromethyl purine derivatives with adenosine-A3 antagonistic activity
SOLVAY PHARM BV4 citations55
US7338964B2Mar 4, 2008
2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity
SOLVAY PHARM BV0 citations44